跳至主要内容
临床试验/JPRN-UMIN000042159
JPRN-UMIN000042159招募中未知

A study to evaluate the long-term effect of Endothelin Receptor Antagonist(ERA) in patients with pulmonary hypertension related with COPD and IPF, respectively. - A study to evaluate the long-term effect of Endothelin Receptor Antagonist(ERA) in patients with pulmonary hypertension related with COPD and IIPS, respectively.

Department of Respiratory Medicine, Nippon Medical School0 个研究点目标入组 150 人开始时间: 2020年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients already on Endothelin Receptor Antagonist or other drugs for pulmonary hypertension 2) Patients with any disease that can cause right heart overload 3) Patients with hypoxemia (PaO2<60mmHg at rest ). 4) Women who are pregnant or who may be pregnant, and lactating women 5) Patients with moderate or severe liver disorder 6) Patients under treatment with ciclosporin, tacrolimus, or glibenclamide 6) Other patients judged by the investigator to be inappropriate as a subject of this study

研究者

发起方
Department of Respiratory Medicine, Nippon Medical School

相似试验